Literature DB >> 14790

Effects of adrenergic amines on electrophysiological properties and automaticity of neonatal and adult canine Purkinje fibers: evidence for alpha- and beta-adrenergic actions.

M R Rosen, A J Hordof, J P Ilvento, P Danilo.   

Abstract

We determined age-related differences in automaticity and responsiveness of cardiac Purkinje fibers from adult and neonatal dogs to graded concentrations of epinephrine, isoproterenol, and phenylephrine. Purkinje fibers were studied with standard microelectrode techniques during superfusion with Tyrode's solution at 37 degrees C. Control spontaneous rates for adults and neonates did not differ significantly. There was a biphasic response to all agonists such that rate decreased at low and increased at high concentrations. The decrease was greater with phenylephrine and epinephrine than with isoproterenol. The increase in rate was greater with isoproterenol and epinephrine than with phenylephrine. Propranolol shifted the dose-response curves downward and to the right for all agonists; phentolamine, shifter the curves upward and to the left. Epinephrine and isoproterenol dose-response curves for the neonates were upward and to the left of those for adults. Phenylephrine curves were identical for adults and neonates. Thus there are alpha- and beta-adrenergic effects on Purkinje fiber automaticity; the former decrease and the latter increase rate. Furthermore, the effects on automiticity of beta-adrenergic amines are greater in the neonates than in the adult.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 14790     DOI: 10.1161/01.res.40.4.390

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  15 in total

1.  Alpha 1-adrenoceptors reduce background K+ current in rabbit ventricular myocytes.

Authors:  D Fedida; A P Braun; W R Giles
Journal:  J Physiol       Date:  1991-09       Impact factor: 5.182

2.  Effects of protein kinase inhibitors on canine Purkinje fibre pacemaker depolarization and the pacemaker current i(f).

Authors:  F Chang; I S Cohen; D DiFrancesco; M R Rosen; C Tromba
Journal:  J Physiol       Date:  1991       Impact factor: 5.182

3.  Enhanced alpha-adrenoceptor responsiveness and receptor number during global ischaemia in the Langendorff perfused rat heart.

Authors:  M C Butterfield; R Chess-Williams
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

4.  Characterization of adrenoceptors mediating positive inotropic responses in the ventricular myocardium of the dog.

Authors:  M Endoh; T Shimizu; T Yanagisawa
Journal:  Br J Pharmacol       Date:  1978-09       Impact factor: 8.739

5.  Effects of selective alpha 1-, alpha 2-, beta 1-and beta 2-adrenoceptor stimulation on potentials and contractions in the rabbit heart.

Authors:  I D Dukes; E M Vaughan Williams
Journal:  J Physiol       Date:  1984-10       Impact factor: 5.182

6.  Stimulation of cardiac alpha receptors increases Na/K pump current and decreases gK via a pertussis toxin-sensitive pathway.

Authors:  A Shah; I S Cohen; M R Rosen
Journal:  Biophys J       Date:  1988-08       Impact factor: 4.033

7.  A pace-maker-like current in the sheep atrium and its modulation by catecholamines.

Authors:  Y E Earm; Y Shimoni; A J Spindler
Journal:  J Physiol       Date:  1983-09       Impact factor: 5.182

8.  Alpha adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats.

Authors:  D J Sheridan; P A Penkoske; B E Sobel; P B Corr
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

9.  Multiple effects of alpha-adrenoceptor stimulation on the action potential of the rabbit atrium.

Authors:  Y Miura; J Inui
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-01       Impact factor: 3.000

10.  Noradrenaline hyperpolarizes cells of the canine coronary sinus by increasing their permeability to potassium ions.

Authors:  P A Boyden; P F Cranefield; D C Gadsby
Journal:  J Physiol       Date:  1983-06       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.